171 related articles for article (PubMed ID: 33886674)
1. Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
Rodríguez-Tomàs E; Arenas M; Gómez J; Acosta J; Trilla J; López Y; Árquez M; Torres L; Araguas P; Hernández-Aguilera A; Baiges-Gaya G; Castañé H; Camps J; Joven J
PLoS One; 2021; 16(4):e0250453. PubMed ID: 33886674
[TBL] [Abstract][Full Text] [Related]
2. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.
Shim BY; Sun S; Won HS; Lee MA; Hong SU; Jung JH; Cho HM; Ko YH
BMC Cancer; 2016 Mar; 16():207. PubMed ID: 26965179
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
4. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review).
Pettit C; Walston S; Wald P; Webb A; Williams TM
Int J Oncol; 2017 Aug; 51(2):393-404. PubMed ID: 28627602
[TBL] [Abstract][Full Text] [Related]
6. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
Sclafani F; Brown G; Cunningham D; Rao S; Tekkis P; Tait D; Morano F; Baratelli C; Kalaitzaki E; Rasheed S; Watkins D; Starling N; Wotherspoon A; Chau I
Oncologist; 2017 Jun; 22(6):728-736. PubMed ID: 28476941
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.
Gasparini G; Torino F; Ueno T; Cascinu S; Troiani T; Ballestrero A; Berardi R; Shishido J; Yoshizawa A; Mori Y; Nagayama S; Morosini P; Toi M
Angiogenesis; 2012 Mar; 15(1):141-50. PubMed ID: 22212406
[TBL] [Abstract][Full Text] [Related]
8. SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy.
Kurtul N; Taşdemir EA; Ünal D; İzmirli M; Eroglu C
Cancer Biomark; 2017; 18(4):459-466. PubMed ID: 28009327
[TBL] [Abstract][Full Text] [Related]
9. Can neoadjuvant radiochemotherapy improve the results of multivisceral resections in advanced rectal carcinoma (cT4a).
Göhl J; Merkel S; Rödel C; Hohenberger W
Colorectal Dis; 2003 Sep; 5(5):436-41. PubMed ID: 12925076
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
11. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
Chiorean EG; Sanghani S; Schiel MA; Yu M; Burns M; Tong Y; Hinkle DT; Coleman N; Robb B; LeBlanc J; Clark R; Bufill J; Curie C; Loehrer PJ; Cardenes H
Cancer Chemother Pharmacol; 2012 Jul; 70(1):25-32. PubMed ID: 22610353
[TBL] [Abstract][Full Text] [Related]
12. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
13. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.
Fan WH; Xiao J; An X; Jiang W; Li LR; Gao YH; Chen G; Kong LH; Lin JZ; Wang JP; Pan ZZ; Ding PR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1461-1467. PubMed ID: 28386648
[TBL] [Abstract][Full Text] [Related]
16. Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.
Florczynski MM; Sanatani MS; Mai L; Fisher B; Moulin DE; Cao J; Louie AV; Pope JE; Leung E
BMC Cancer; 2016 Mar; 16():243. PubMed ID: 27000107
[TBL] [Abstract][Full Text] [Related]
17. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M
Int J Clin Oncol; 2016 Apr; 21(2):350-358. PubMed ID: 26370256
[TBL] [Abstract][Full Text] [Related]
19. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy].
Zhang D; Zhan T; Li M; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):519-523. PubMed ID: 28534328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
